Back to Journals » Journal of Biorepository Science for Applied Medicine » Volume 3 » Issue 1

Sample PREanalytical Code for labeling of biospecimens: an analysis of specimen labeling protocols

Authors Riondino S, Nanni U, Betsou F, Rossetti L, Campisi C, Fiorentino R, Palmirotta R, Ferroni P, Roselli M, Guadagni F

Received 15 March 2015

Accepted for publication 15 May 2015

Published 17 July 2015 Volume 2015:3(1) Pages 15—21

DOI https://doi.org/10.2147/BSAM.S68062

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 6

Editor who approved publication: Dr Martin H. Bluth

Silvia Riondino,1* Umberto Nanni,2* Fay Betsou,3 Luisa Rossetti,2 Corrado Campisi,4 Riccardo Fiorentino,1 Raffaele Palmirotta,1 Patrizia Ferroni,1 Mario Roselli,5 Fiorella Guadagni1

1BioBIM-Interinstitutional Multidisciplinary BioBank, IRCCS San Raffaele Pisana – Research Center, Rome, Italy; 2Department of Computer, Control and Management Engineering "Antonio Ruberti", "Sapienza" University, Rome, Italy; 3Integrated Biobank of Luxembourg, Luxembourg City, Luxembourg; 4LC Campisi Laboratory Ltd, Avola (SR), Italy; 5Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy

*These authors contributed equally to this work

Abstract: The suitability of samples for a given research depends on many variables, among which, the best preanalytical conditions for the type of test that should be carried out. Thus, standardization and harmonization of processing conditions for samples entering a particular study should be highly pursued to facilitate research collaborations among different institutions and biological banks, allowing specimen comparison both for sample sharing and for the development of large-scale clinical trials. In this study, we review some issues and scenarios related to the adoption of the Sample PREanalytical Code, which deserve attention for a proper management of the samples and, ultimately, for maximizing the efficiency of the consistent investments required to set up biobanking resources.

Keywords: biobanking, preanalytical variables, sample labeling
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Acquired hemophilia A: emerging treatment options

Janbain M, Leissinger CA, Kruse-Jarres R

Journal of Blood Medicine 2015, 6:143-150

Published Date: 8 May 2015

Second case report of successful electroconvulsive therapy for a patient with schizophrenia and severe hemophilia A

Saito N, Shioda K, Nisijima K, Kobayashi T, Kato S

Neuropsychiatric Disease and Treatment 2014, 10:865-867

Published Date: 16 May 2014

Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision

Espandar L, Sikder S, Moshirfar M

Clinical Ophthalmology 2011, 5:159-160

Published Date: 6 February 2011

The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, et al

International Journal of Nanomedicine 2010, 5:581-591

Published Date: 6 August 2010